The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Open accessAbstract
The clinical courses of 13 consecutive intravenous drug users with Staphylococcus aureus endocarditis treated principally with vancomycin were reviewed. Two patients, one with only right-sided endocarditis and the other with tricuspid and mitral valve endocarditis, had recurrences of positive blood cultures 2 days after completing a 4-week course of vancomycin. Two patients, both of whom eventually were cured, had modifications of therapy because of bacteremia persisting 7 and 16 days into therapy. One patient required an operation for recurrent fevers, and the resected vegetation showed evidence of active infection. Time-kill studies performed with nafcillin and vancomycin for 10 isolates of S. aureus showed that vancomycin was less rapidly bactericidal than nafcillin. Although vancomycin is used as an alternative to penicillinase-resistant penicillins for treatment of staphylococcal endocarditis, these findings raise the question of whether it is equivalent to these drugs in efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KORZENIOWSKI, O., & SANDE, M. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-4-496 · Cited by 355
Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus
SORRELL, T. C., PACKHAM, D. R., SHANKER, S., FOLDES, M., & MUNRO, R. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-344 · Cited by 260
LEVINE, D. P., CUSHING, R. D., JUI, J., & BROWN, W. J. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-330 · Cited by 224
Chambers, H. F., Miller, R. T., & Newman, M. D. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-8-619 · Cited by 214
Self-citationStaphylococcus aureus Endocarditis: Combined Therapy With Vancomycin and Rifampin
Faville, R. J. (1978) · JAMA · doi:10.1001/jama.1978.03290180037019 · Cited by 158
Weinstein, M. P., Stratton, C. W., Ackley, A. M., Hawley, H. B., Robinson, P. A., Fisher, B. D., Alcid, D. V., Stephens, D. S., & Reller, L. B. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90436-x · Cited by 149
Favorable Experience with Bacterial Endocarditis in Heroin Addicts
Menda, K. B., & GORBACH, S. L. (1973) · Annals of Internal Medicine · doi:10.7326/0003-4819-78-1-25 · Cited by 143
Single or Combination Therapy of Staphylococcal Endocarditis in Intravenous Drug Abusers
ABRAMS, B., SKLAVER, A., HOFFMAN, T., & Greenman, R. L. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-5-789 · Cited by 125
Clinical Significance of Tolerant Strains of Staphylococcus aureus in Patients with Endocarditis
RAJASHEKARAIAH, K. R., RICE, T., RAO, V. S., MARSH, D., RAMAKRISHNA, B., & KALLICK, C. A. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-796 · Cited by 117
Gopal, V. (1976) · JAMA · doi:10.1001/jama.236.14.1604 · Cited by 108
The Efficacy of Rifampin as Adjunctive Therapy in Selected Cases of Staphylococcal Endocarditis
Massanari, R. M., & Donta, S. T. (1978) · CHEST Journal · doi:10.1378/chest.73.3.371 · Cited by 85
Staphylococcal Endocarditis in Drug Users: Clinical and Microbiologic Aspects
Tuazon, C. U., Cardella, T. A., & Sheagren, J. N. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.135.12.1555 · Cited by 75
Karchmer, A. W. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90374-2 · Cited by 72
Intravenous Followed by Oral Antimicrobial Therapy for Staphylococcal Endocarditis
Parker, R. H., & FOSSIECK, B. E. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-832 · Cited by 63
Vancomycin Therapy for Infective Endocarditis
GERACI, J. E., & Wilson, W. R. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.supplement.s250 · Cited by 62
Staphylococcal bacteremia and endocarditis: state of the art
Bayer, A. S. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.142.6.1169 · Cited by 47
Staphylococcal Endocarditis in Addicts
Sklaver, A. R., Hoffman, T. A., & Greenman, R. L. (1978) · Southern Medical Journal · doi:10.1097/00007611-197806000-00009 · Cited by 43
Persistent staphylococcal bacteremia in an intravenous drug abuser
Barg, N. L., Supena, R. B., & Fekety, R. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.2.209 · Cited by 31
Greenman, R. L., Arcey, S., Gutterman, D. L., & Zweig, R. M. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.1.16 · Cited by 17
Jj, G., Regnier, B., Lassoued, K., et al. (1985) · PubMed · Cited by 8
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Self-citationGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Metadata
- Authors
- Small, P. M., & Chambers, H. F.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1990-06
- Volume
- 34
- Issue
- 6
- Pages
- 1227-1231
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2044087791
- Cited by
- 399
- References
- 20
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.